ArticleClinical kidney journal2023

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA).

Pantelis Sarafidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.